Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in knee osteoarthritis
NCT04326894Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Dec 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methotrexate in knee osteoarthritis (OA), sponsored by Alexandria University. Primary endpoint: Pain reduction at 8 months. Started Dec 2011; status: completed.
02
Drugs
methotrexate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04326894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04326894.